MAPT and Alzheimer disease: The pathological roles of these proteins in the human brain during AD have been investigated using positron emission tomography (PET), with radiotracers such as [ 18F]florbetapir and [ 18F]flortaucipir allowing for in-vivo quantification of Aβ and tau, respectively [3].